Survival Is Poorer in Patients With Secondary Core Binding Factor Acute Myelogenous Leukemia Compared With De Novo Core Binding Factor Leukemia.

Blood - United States
doi 10.1182/blood.v110.11.2856.2856
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology